Regulatory risk Recent multi-million settlement related to AKS and False Claims Act indicates heightened compliance scrutiny for Cardiac Imaging. Sales teams should emphasize robust compliance programs, transparent pricing, and third-party risk assessments when engaging hospitals and physician groups to mitigate reputational and legal risk.

Strategic partnerships Existing collaboration with DraxImage for daily-leased rubidium supply presents a template for co-marketing and bundled service offerings. Explore similar OEM or distributor partnerships to expand mobile PET reach and reduce capital barriers for client facilities.

Mobile clinic strength Specialization in mobile cardiac PET clinics combined with turnkey fixed-site installations offers a unique value proposition for health systems seeking flexible imaging deployment. Target multisite health networks and physician groups looking to expand cardiac PET access with minimal in-house infrastructure.

Gold standard imaging Cardiac PET is positioned as the gold standard for early coronary artery disease detection. Market to cardiology departments and primary care referral networks emphasizing superior diagnostic yield, early intervention potential, and differentiated patient outcomes to drive adoption.

Scale and revenue Reported revenue range suggests substantial market presence with mid-market scale. Identify mid-to-large health systems and regional hospital networks as targets for scalable imaging programs, offering phased expansion, bundled services, and performance-based pricing tied to diagnostic efficiency.